摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-butoxyphenylmethyl)(4-octylphenyl)amine

中文名称
——
中文别名
——
英文名称
(4-butoxyphenylmethyl)(4-octylphenyl)amine
英文别名
N-[(4-butoxyphenyl)methyl]-4-octylaniline
(4-butoxyphenylmethyl)(4-octylphenyl)amine化学式
CAS
——
化学式
C25H37NO
mdl
——
分子量
367.575
InChiKey
KJISCBYTKUMLQV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.7
  • 重原子数:
    27
  • 可旋转键数:
    14
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (4-butoxyphenylmethyl)(4-octylphenyl)amine2,6-二异丙基苯异氰酸酯 以N-(4-butoxyphenylmethyl)-N′-(2,6-diisopropylphenyl)-N-(4-octylphenyl)urea (0.92 g) was obtained的产率得到N-(4-butoxyphenylmethyl)-N'-(2,6-diisopropylphenyl)-N-(4-octylphenyl)urea
    参考文献:
    名称:
    Novel 3-substituted urea derivatives and medicinal use thereof
    摘要:
    本发明涉及一种尿素衍生物,其化学式为(1)其中符号如说明书所述,其药学上可接受的盐及其药用。本发明化合物具有C5a受体拮抗作用,可用作预防或治疗由C5a引起的炎症所致的疾病或综合症的药剂,例如自身免疫性疾病,如风湿病、系统性红斑狼疮等,败血症、成人呼吸窘迫综合症、慢性阻塞性肺疾病、哮喘等过敏性疾病、动脉粥样硬化、心肌梗死、脑梗死、牛皮癣、阿尔茨海默病和严重器官损伤(例如肺炎、肾炎、肝炎、胰腺炎等)由于缺血、创伤、烧伤、手术入侵等引起的白细胞激活。此外,它还可用作预防或治疗由细菌或病毒通过C5a受体侵入引起的感染性疾病的药剂。
    公开号:
    US20030207939A1
点击查看最新优质反应信息

文献信息

  • Novel 3-substituted urea derivatives and medicinal use thereof
    申请人:——
    公开号:US20030207939A1
    公开(公告)日:2003-11-06
    The present invention relates to a urea derivative of the formula (1) 1 wherein each symbol is as described in the specification, a pharmaceutically acceptable salt thereof and pharmaceutical use thereof. The compound of the present invention has a C5a receptor antagonistic action and is useful as an agent for the prophylaxis or treatment of diseases or syndromes due to inflammation caused by C5a [e.g., autoimmune diseases such as rheumatism, systemic lupus erythematosus and the like, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergic diseases such as asthma and the like, atherosclerosis, cardiac infarction, brain infarction, psoriasis, Alzheimer's disease and serious organ injury (e.g., pneumonia, nephritis, hepatitis, pancreatitis and the like) due to activation of leukocytes caused by ischemia, trauma, burn, surgical invasion and the like]. In addition, it is useful as an agent for the prophylaxis or treatment of infectious diseases caused by bacteria or virus that invades via a C5a receptor.
    本发明涉及一种化学式(1)1的尿素衍生物,其中每个符号如规范中所述,以及其药用可接受盐和药用。本发明的化合物具有C5a受体拮抗作用,可用作预防或治疗由C5a引起的炎症所致疾病或综合症的药剂[例如,自身免疫疾病如风湿病、系统性红斑狼疮等、败血症、成人呼吸窘迫综合征、慢性阻塞性肺疾病、哮喘等过敏性疾病、动脉粥样硬化、心肌梗死、脑梗死、牛皮癣、阿尔茨海默病和严重器官损伤(例如,由缺血、创伤、烧伤、手术侵袭等引起的白细胞活化引起的肺炎、肾炎、肝炎、胰腺炎等)。此外,它还可用作预防或治疗由细菌或病毒通过C5a受体侵入引起的传染病的药剂。
  • 3-SUBSTITUTED UREA DERIVATIVES AND MEDICINAL USE THEREOF
    申请人:Mitsubishi Tanabe Pharma Corporation
    公开号:EP1308438B9
    公开(公告)日:2012-03-28
  • US7105567B2
    申请人:——
    公开号:US7105567B2
    公开(公告)日:2006-09-12
  • 3-substituted urea derivatives and medicinal use thereof
    申请人:Mitsubishi Pharma Corporation
    公开号:US07105567B2
    公开(公告)日:2006-09-12
    The present invention relates to a urea derivative of the formula (1) wherein each symbol is as described in the specification, a pharmaceutically acceptable salt thereof and pharmaceutical use thereof. The compound of the present invention has a C5a receptor antagonistic action and is useful as an agent for the prophylaxis or treatment of diseases or syndromes due to inflammation caused by C5a [e.g., autoimmune diseases such as rheumatism, systemic lupus erythematosus and the like, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergic diseases such as asthma and the like, atherosclerosis, cardiac infarction, brain infarction, psoriasis, Alzheimer's disease and serious organ injury (e.g., pneumonia, nephritis, hepatitis, pancreatitis and the like) due to activation of leukocytes caused by ischemia, trauma, burn, surgical invasion and the like]. In addition, it is useful as an agent for the prophylaxis or treatment of infectious diseases caused by bacteria or virus that invades via a C5a receptor.
    本发明涉及一种尿素衍生物(1)的公式,其中每个符号如规范所述,其药学上可接受的盐及其药用。本发明的化合物具有C5a受体拮抗作用,可用作预防或治疗由C5a引起的炎症所致的疾病或综合征的药剂[例如,自身免疫性疾病,如风湿病,系统性红斑狼疮等,败血症,成人呼吸窘迫综合征,慢性阻塞性肺疾病,过敏性疾病,如哮喘等,动脉粥样硬化,心脏梗塞,脑梗塞,牛皮癣,阿尔茨海默病和严重器官损伤(例如肺炎,肾炎,肝炎,胰腺炎等),由缺血,创伤,烧伤,手术侵入等引起的白细胞激活所致]。此外,它还可用作预防或治疗由通过C5a受体侵入的细菌或病毒引起的感染性疾病的药剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐